009 — Salem, Oregon

009 is a clinical research site located in Salem, Oregon, United States.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

009 has participated in 1 clinical trials.

Therapeutic areas: Conditions for Which There is a Documented Medical Necessity to Receive Treatment With Rotigotine.

Sponsors: UCB Pharma.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Salem

Browse all research sites in Oregon · View every site in Salem

• Salem Hospital
• Salem Hospital Regional Cancer Center
• Salem Hospital Regional Cancer Care Services
• Oregon Center for Clinical Investigations
• Research Site
• Oregon Oncology Specialists
• OCCI Inc
• Retina Consultants, LLC
• Salem Health
• GSK Investigational Site
• Pfizer Investigational Site
• Clinical Research Site

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 009?

009 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 009 conducted?

009 has 1 clinical trials on record. Their work covers Conditions for Which There is a Documented Medical Necessity to Receive Treatment With Rotigotine.

Is 009 accredited by Crixeo Clinical Trials?

009 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 009?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.